- Johnson & Johnson (JNJ) is currently "stressed" to meet EU vaccine targets - Reuters reports, citing an EU official
Market news
9 March 2021
Johnson & Johnson (JNJ) is currently "stressed" to meet EU vaccine targets - Reuters reports, citing an EU official
Last week, Johnson & Johnson (JNJ) informed the EU that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the plan of delivering 55 million doses by the end of Q2, the EU official, directly involved in talks with J&J, told Reuters. He, however, added the company had said it was not impossible to meet the goal, but that it showed caution.
Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerOpen Demo Account & Personal Page